Tyre Grant is a seasoned professional in pharmaceutical and animal health product development with extensive experience in leadership roles. Currently serving as Vice President of Global Product Development & Project Management at Elanco since February 2018, Tyre Grant directly manages cross-functional teams and provides strategic direction for the development and global registration of pharmaceutical products. Prior to Elanco, Tyre Grant held various leadership positions at Eli Lilly and Company, including Director of Companion Animal Research and Development, overseeing global R&D teams for companion animal health products. Tyre Grant's career began at the FDA’s Forensic Chemistry Center, followed by obtaining a Ph.D. in Analytical Chemistry from the University of Cincinnati and a BS in Chemistry from Wittenberg University.
Elanco
26 followers
Elanco Animal Health Incorporated is an animal health company that develops, manufactures and markets products for companion and food animals. The Company offers its products under four primary categories, such as Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine.